Anticoagulation for patients with atrial fibrillation and risk factors for stroke. Warfarin reduces the risk by two thirds, but doctors still aren't prescribing it enough

Editorial

S J Connolly. BMJ. 2000.

. 2000 May 6;320(7244):1219-20.

doi: 10.1136/bmj.320.7244.1219.

No abstract available

Comment in

Anticoagulation for patients with atrial fibrillation. Editorial may have overinterpreted data.
Dudley N. Dudley N. BMJ. 2000 Sep 9;321(7261):638-9. doi: 10.1136/bmj.321.7261.638. BMJ. 2000. PMID: 11023330 Free PMC article. No abstract available.
Anticoagulation for patients with atrial fibrillation. Warfarin should be given for up to one year after successful cardioversion.
Berry C, McMurray J. Berry C, et al. BMJ. 2000 Sep 9;321(7261):639. BMJ. 2000. PMID: 11023332 No abstract available.
Anticoagulation to prevent stroke in atrial fibrillation. It's still not clear whether results in secondary care translate to primary care.
Fitzmaurice DA, Mant J, Murray ET, Hobbs FD. Fitzmaurice DA, et al. BMJ. 2000 Nov 4;321(7269):1156. BMJ. 2000. PMID: 11203222 Free PMC article. Clinical Trial. No abstract available.
General practitioners have to decide best ways of allocating their time.
Oliver MD. Oliver MD. BMJ. 2000 Nov 4;321(7269):1156-7. BMJ. 2000. PMID: 11203224 No abstract available.

Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness.
Kalra L, Yu G, Perez I, Lakhani A, Donaldson N. Kalra L, et al. BMJ. 2000 May 6;320(7244):1236-9. doi: 10.1136/bmj.320.7244.1236. BMJ. 2000. PMID: 10797031 Free PMC article.

1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic treatment in atrial fibrillation: analysis of pooled data from five randomized controlled studies. Arch Intern Med. 1994;154:1449–1457. - PubMed
1. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low intensity fixed dose warfarin plus aspirin for high risk patients with atrial fibrillation. Stroke prevention in atrial fibrillation III randomized trial. Lancet. 1996;348:633–638. - PubMed
1. Laupacis A, Albers G, Dalen J, Dunn M, Feinberg W, Jacobson A. Antithrombotic therapy in atrial fibrillation. Chest. 1995;108(suppl):352–39S. - PubMed
1. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998;352:1167–1171. - PubMed
1. Clinical Quality Improvement Network. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. Can J Cardiol. 1998;14:695–702. - PubMed